(Q29030056)

English

7-Chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-1-benzazepine (OPC-41061): A potent, orally active nonpeptide arginine vasopressin V2 receptor antagonist

scientific article (publication date: August 1999)

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482466%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

7-Chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoyl-amino)benzoyl ]-2,3,4,5-tetrahydro-1H-1-benzazepine (OPC-41061): a potent, orally active nonpeptide arginine vasopressin V2 receptor antagonist (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482466%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

0 references

author name string

K Kondo

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482466%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

H Ogawa

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482466%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

H Yamashita

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482466%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

H Miyamoto

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482466%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

M Tanaka

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482466%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

K Nakaya

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482466%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

K Kitano

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482466%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

Y Yamamura

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482466%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

S Nakamura

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482466%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

T Onogawa

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482466%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

T Mori

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482466%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

M Tominaga

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482466%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

language of work or name

0 references

publication date

1 August 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482466%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

Bioorganic & Medicinal Chemistry

2 references

DOI.org query endpoint

https://doi.org/10.1016%2FS0968-0896%2899%2900101-7

26 March 2017

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482466%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

7

2 references

DOI.org query endpoint

https://doi.org/10.1016%2FS0968-0896%2899%2900101-7

26 March 2017

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482466%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

8

2 references

DOI.org query endpoint

https://doi.org/10.1016%2FS0968-0896%2899%2900101-7

26 March 2017

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482466%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1743-1754

2 references

DOI.org query endpoint

https://doi.org/10.1016%2FS0968-0896%2899%2900101-7

26 March 2017

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482466%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

Design, synthesis and some uses of receptor-specific agonists and antagonists of vasopressin and oxytocin

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900101-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Osmotically induced basolateral K+ conductance in turtle colon: lidocaine-induced K+ channel noise.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900101-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Orally active, nonpeptide vasopressin V2 receptor antagonists: a novel series of 1-[4-(benzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepines and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900101-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900101-7

7 January 2021

based on heuristic

inferred from DOI database lookup

5-Fluoro-2-methyl-N-[4-(5H-pyrrolo[2,1-c]-[1, 4]benzodiazepin-10(11H)-ylcarbonyl)-3-chlorophenyl]benzamide (VPA-985): an orally active arginine vasopressin antagonist with selectivity for V2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900101-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonpeptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 2-phenyl-4'-[(2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl]benzanil ide derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900101-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900101-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonpeptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 2-phenyl-4'-(2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-1-carbonyl) benzanilide derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900101-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonpeptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 4'-[5-(substituted methylidene)-2,3,4,5-tetrahydro-1H-1-ben zoazepine-1-carbonyl]benzanilide and 4'-[5-(substituted methyl)-2,3-di

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900101-7

7 January 2021

based on heuristic

inferred from DOI database lookup

1,4-dihydro-2,3-quinoxalinediones as potential flavin metabolites and excitatory amino acid receptor ligands. Part 1: Synthesis and pharmacological evaluation of the benzylic oxidation series of 1,4-dihydro-6,7-dimethyl-2,3-quinoxalinedione

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900101-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure-activity relationships of non-peptide vasopressin V1a antagonists: 1-(1-multi-substituted benzoyl 4-piperidyl)-3,4-dihydro-2(1H)-quinolinones

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900101-7

7 January 2021

based on heuristic

inferred from DOI database lookup

OPC-21268, an Orally Effective, Nonpeptide Vasopressin V1 Receptor Antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900101-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0968-0896(99)00101-7

2 references

DOI.org query endpoint

https://doi.org/10.1016%2FS0968-0896%2899%2900101-7

26 March 2017

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482466%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10482466%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q29030056&oldid=1413415614"